FpML-EQD Version 2 Fw: FpML EQD WG Agenda 1400 LDN Fri 16 May 2008

[andrew.p.parry@xxxxxxxxxxxx]

Version 2 and attached below

Andrew Parry
+44 20 7325 1486
Exotics and Hybrids Architecture
JP Morgan

----- Forwarded by Andrew
P Parry/JPMCHASE on 15/05/2008 16:24 -----

Andrew P Parry/JPMCHASE

15/05/2008 09:23

To	fpml eqdwg
cc	Matthew D Rawlings/JPMCHASE@JPMCHASE, Mark A Addison/JPMCHASE@JPMCHASE
Subject	FpML EQD WG Agenda 1400 LDN Fri 16 May 2008

* Telephone Conference

US: 1 888 481 3032
UK: 0 800 904 7961
Intl: 1 617 801 9600

Participant code: 8682747


* Agenda

1. Actions from 1400 LDN Fri 02 May
2008

KE provide ISDA perspective on what
is driving the complexity of the legal drafting process
AP make schema changes for FpML-4-4
release within branch "FpML-4-4-5-LCWD-1-EQD" created from tag
"FpML-4-4-5-LCWD-1-EQD"
RM determine treatment of linear interpolation

** FpML-4-4 source code changes **

1. add optional element relevantJurisdiction
IS-A Country on type EquitySwapTransactionSupplement, with annotation as
per "2008 AEJ EFS FpML proposal.doc" from Robert Masri, DTCC
[ AP done ]
2. add “ISDA2008EquityFinanceSwapAsiaExcludingJapan”
scheme should be added to "master-confirmation-type.xml", with
annotation as per "2008 AEJ EFS FpML proposal.doc" from Robert
Masri, DTCC  [ IY done]
3. make element notionalReset IS-A xsd:boolean
optional on type ReturnLegValuation [ AP done ]
4. make element settlementType optional
within OptionSettlement.model [ IY done ]
5. add optional element nonCashDividend
IS-A xsd:boolean as the last child of type DividendLeg [ AP done ]


2. Actions from 1400 LDN Fri 09 May
2008

MG make XQuery implementation of FpML
business rules available for download on FpML web site
AP propose solution to issue 682
AP review rule context for complex types
Trade vs Contract vs Strategy ( related to issue 675 )
AP review using of type Compounding
within EquityDerivatives
IY commit resolution for issue 674 

** FpML-4-4 source code changes ***

None required from our group. Element
compounding IS-A Compounding is an optional child of InterestCalculation,
which is only used within InterestLeg of Return Swaps. Since compounding
is optional within the EQD product scope, we are not exposed to the value
'None' within CompoundingMethodEnum

** Business rule issue **

http://www.fpml.org/issues/view.php?id=682

We have discussed that integralMultipleExercise
is not applicable for the last exercise ( automatic or manual ) as per
Robert Masri and Piers Evans. Since we cannot capture 'last exercise' as
a context, we may have to remove rule eqd-17

** Business rule context **

EQD business rules to date are based
on a product context, such as 'EquityOption' which is applicable to Trade,
Contract, and Strategy. Automated production of a rule context list would
be welcome

3. Swaps Wire Proposal : Interest Leg
Calculation Period

Please see attached 'intLegDatesProposal.zip'
from Takeo Asakura of Swaps Wire



4. Issues

http://www.fpml.org/issues/view.php?id=702

http://www.fpml.org/issues/view.php?id=702

http://www.fpml.org/issues/view.php?id=702

http://www.fpml.org/issues/view.php?id=702

http://www.fpml.org/issues/view.php?id=701

http://www.fpml.org/issues/view.php?id=700

http://www.fpml.org/issues/view.php?id=699

http://www.fpml.org/issues/view.php?id=698

http://www.fpml.org/issues/view.php?id=686

http://www.fpml.org/issues/view.php?id=685

http://www.fpml.org/issues/view.php?id=684

http://www.fpml.org/issues/view.php?id=683

http://www.fpml.org/issues/view.php?id=682

http://www.fpml.org/issues/view.php?id=680

http://www.fpml.org/issues/view.php?id=679

http://www.fpml.org/issues/view.php?id=677

http://www.fpml.org/issues/view.php?id=675

http://www.fpml.org/issues/view.php?id=673

http://www.fpml.org/issues/view.php?id=672

http://www.fpml.org/issues/view.php?id=671


5. AOB


Regards

Andrew Parry
+44 20 7325 1486
Exotics and Hybrids Architecture
JP Morgan

---

This communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice. Any comments or statements made herein do not necessarily reflect those of JPMorgan Chase & Co., its subsidiaries and affiliates. This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. Thank you. Please refer to http://www.jpmorgan.com/pages/disclosures for disclosures relating to UK legal entities.

Attachment: intLegDatesProposal.zip
Description: Zip archive